156 related articles for article (PubMed ID: 34711185)
1. Development and validation of genomic and epigenomic signatures associated with tumor immune microenvironment in hepatoblastoma.
Zhang Y; Zhang T; Yin Q; Luo H
BMC Cancer; 2021 Oct; 21(1):1156. PubMed ID: 34711185
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of
Liu L; Cui Z; Zhang J; Wang J; Gu S; Ma J; Chen H; Hang L; Yang J; Shi Y
Cancer Biother Radiopharm; 2020 Feb; 35(1):41-49. PubMed ID: 31916845
[No Abstract] [Full Text] [Related]
3. Activation of β-catenin and Yap1 in human hepatoblastoma and induction of hepatocarcinogenesis in mice.
Tao J; Calvisi DF; Ranganathan S; Cigliano A; Zhou L; Singh S; Jiang L; Fan B; Terracciano L; Armeanu-Ebinger S; Ribback S; Dombrowski F; Evert M; Chen X; Monga SPS
Gastroenterology; 2014 Sep; 147(3):690-701. PubMed ID: 24837480
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of SFRP1 is a protumorigenic event in hepatoblastoma and correlates with beta-catenin mutations.
Regel I; Eichenmüller M; Mahajan UM; Hagl B; Benitz S; Häberle B; Vokuhl C; von Schweinitz D; Kappler R
J Cancer Res Clin Oncol; 2020 May; 146(5):1153-1167. PubMed ID: 32189106
[TBL] [Abstract][Full Text] [Related]
5. Hepatoblastomas exhibit marked
Rivas MP; Aguiar TFM; Maschietto M; Lemes RB; Caires-Júnior LC; Goulart E; Telles-Silva KA; Novak E; Cristofani LM; Odone V; Cypriano M; de Toledo SRC; Carraro DM; Escobar MQ; Lee H; Johnston M; da Costa CML; da Cunha IW; Tasic L; Pearson PL; Rosenberg C; Timchenko N; Krepischi ACV
Tumour Biol; 2020 Dec; 42(12):1010428320977124. PubMed ID: 33256542
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of dishevelled-2 inhibits cell proliferation and invasion in hepatoblastoma.
Huang S; Chen J; Tian R; Wang J; Xie C; Gao H; Shan Y; Hong J; Zhang Z; Xu M; Gu S
Pediatr Blood Cancer; 2018 Jul; 65(7):e27032. PubMed ID: 29528187
[TBL] [Abstract][Full Text] [Related]
7. Bioinformatics analysis of aberrantly methylated-differentially expressed genes and pathways in hepatocellular carcinoma.
Sang L; Wang XM; Xu DY; Zhao WJ
World J Gastroenterol; 2018 Jun; 24(24):2605-2616. PubMed ID: 29962817
[TBL] [Abstract][Full Text] [Related]
8. Methylation changes in the human IGF2 p3 promoter parallel IGF2 expression in the primary tumor, established cell line, and xenograft of a human hepatoblastoma.
Eriksson T; Frisk T; Gray SG; von Schweinitz D; Pietsch T; Larsson C; Sandstedt B; Ekström TJ
Exp Cell Res; 2001 Oct; 270(1):88-95. PubMed ID: 11597130
[TBL] [Abstract][Full Text] [Related]
9. Promoter-specific methylation and expression alterations of igf2 and h19 are involved in human hepatoblastoma.
Li X; Kogner P; Sandstedt B; Haas OA; Ekström TJ
Int J Cancer; 1998 Jan; 75(2):176-80. PubMed ID: 9462704
[TBL] [Abstract][Full Text] [Related]
10. LASP2 is downregulated in human liver cancer and contributes to hepatoblastoma cell malignant phenotypes through MAPK/ERK pathway.
Li J; Hu S; Zhang Z; Qian L; Xue Q; Qu X
Biomed Pharmacother; 2020 Jul; 127():110154. PubMed ID: 32325347
[TBL] [Abstract][Full Text] [Related]
11. ARID1B/SUB1-activated lncRNA HOXA-AS2 drives the malignant behaviour of hepatoblastoma through regulation of HOXA3.
Liu G; Liu B; Liu X; Xie L; He J; Zhang J; Dong R; Ma D; Dong K; Ye M
J Cell Mol Med; 2021 Apr; 25(7):3524-3536. PubMed ID: 33683826
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value and immune infiltration of a novel stromal/immune score-related P2RY12 in lung adenocarcinoma microenvironment.
Yu L; Cao S; Li J; Han B; Zhong H; Zhong R
Int Immunopharmacol; 2021 Sep; 98():107734. PubMed ID: 34175738
[TBL] [Abstract][Full Text] [Related]
13. Cross talk between RNA N6-methyladenosine methyltransferase-like 3 and miR-186 regulates hepatoblastoma progression through Wnt/β-catenin signalling pathway.
Cui X; Wang Z; Li J; Zhu J; Ren Z; Zhang D; Zhao W; Fan Y; Zhang D; Sun R
Cell Prolif; 2020 Mar; 53(3):e12768. PubMed ID: 31967701
[TBL] [Abstract][Full Text] [Related]
14. LncRNA XIST facilitates cell growth, migration and invasion via modulating H3 histone methylation of DKK1 in neuroblastoma.
Zhang J; Li WY; Yang Y; Yan LZ; Zhang SY; He J; Wang JX
Cell Cycle; 2019 Aug; 18(16):1882-1892. PubMed ID: 31208278
[TBL] [Abstract][Full Text] [Related]
15. Identification of aberrantly methylated differentially expressed genes in breast cancer by integrated bioinformatics analysis.
Yi L; Luo P; Zhang J
J Cell Biochem; 2019 Sep; 120(9):16229-16243. PubMed ID: 31081184
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of aberrantly expressed methylation genes in human hepatocellular carcinoma.
Zhen L; Ning G; Wu L; Zheng Y; Yang F; Chen T; Xu W; Liu Y; Xie C; Peng L
Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 32955083
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of
Beck A; Trippel F; Wagner A; Joppien S; Felle M; Vokuhl C; Schwarzmayr T; Strom TM; von Schweinitz D; Längst G; Kappler R
Clin Epigenetics; 2018; 10():27. PubMed ID: 29507645
[TBL] [Abstract][Full Text] [Related]
18. Identification of prognostic biomarkers associated with the occurrence of portal vein tumor thrombus in hepatocellular carcinoma.
Lin T; Lin Z; Mai P; Zhang E; Peng L
Aging (Albany NY); 2021 Apr; 13(8):11786-11807. PubMed ID: 33878734
[TBL] [Abstract][Full Text] [Related]
19. Targeting long non-coding RNA-TUG1 inhibits tumor growth and angiogenesis in hepatoblastoma.
Dong R; Liu GB; Liu BH; Chen G; Li K; Zheng S; Dong KR
Cell Death Dis; 2016 Jun; 7(6):e2278. PubMed ID: 27362796
[TBL] [Abstract][Full Text] [Related]
20. Identification of invasion-metastasis-associated microRNAs in hepatocellular carcinoma based on bioinformatic analysis and experimental validation.
Lou W; Chen J; Ding B; Chen D; Zheng H; Jiang D; Xu L; Bao C; Cao G; Fan W
J Transl Med; 2018 Sep; 16(1):266. PubMed ID: 30268144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
